PSUF
ALXN

People's United Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

People's United Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,564
Closed -$287K – 747
2021
Q2 		$287K Sell
1,564
-144
-8% -$24.7K 0.01% 626
2021
Q1 		$261K Sell
1,708
-315
-16% -$48.7K 0.01% 621
2020
Q4 		$316K Sell
2,023
-58
-3% -$7.45K 0.01% 556
2020
Q3 		$238K Sell
2,081
-272
-12% -$29.3K 0.01% 578
2020
Q2 		$264K Buy
+2,353
New +$250K 0.01% 548
2019
Q3 		– Sell
-1,864
Closed -$244K – 775
2019
Q2 		$244K Buy
1,864
+5
+0.3% +$644 0.01% 691
2019
Q1 		$252K Buy
+1,859
New +$231K 0.01% 646
2017
Q3 		– Sell
-150
Closed -$18K – 979
2017
Q2 		$18K Hold
150
– – ﹤0.01% 851
2017
Q1 		$18K Hold
150
– – ﹤0.01% 836
2016
Q4 		$18K Hold
150
– – ﹤0.01% 813
2016
Q3 		$18K Hold
150
– – ﹤0.01% 679
2016
Q2 		$18K Buy
150
+115
+329% +$16.3K ﹤0.01% 680
2016
Q1 		$5K Hold
35
– – ﹤0.01% 782
2015
Q4 		$7K Hold
35
– – ﹤0.01% 754
2015
Q3 		$5K Hold
35
– – ﹤0.01% 774
2015
Q2 		$6K Hold
35
– – ﹤0.01% 738
2015
Q1 		$6K Hold
35
– – ﹤0.01% 726
2014
Q4 		$6K Hold
35
– – ﹤0.01% 728
2014
Q3 		$6K Hold
35
– – ﹤0.01% 722
2014
Q2 		$5K Hold
35
– – ﹤0.01% 749
2014
Q1 		$5K Hold
35
– – ﹤0.01% 731
2013
Q4 		$5K Hold
35
– – ﹤0.01% 729
2013
Q3 		$4K Hold
35
– – ﹤0.01% 742
2013
Q2 		$3K Buy
+35
New +$3.37K ﹤0.01% 714

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

People's United Financial's ALXN Position: Q3 2021 in Review

People's United Financial sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,564 shares — an estimated $287K sold.

People's United Financial first reported a position in ALXN in Q2 2013 and held it in 24 quarters. The position peaked at $316K in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • People's United Financial reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • People's United Financial sold 1,564 Alexion Pharmaceuticals shares in Q3 2021, an estimated $287K.
  • People's United Financial first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 24 quarters.
  • People's United Financial's Alexion Pharmaceuticals position peaked at $316K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on People's United Financial's 13F filing for Q3 2021, filed 12 Nov 2021.